A Study to Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02219724 · COMPLETED
Trial details
- NCT number
- NCT02219724
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-12
- Primary completion
- 2017-07-14
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.